Life ScienceCompany
Audentes Therapeutics M&A Summary
Audentes Therapeutics has acquired 1 company of its own.
Audentes Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Audentes Therapeutics Ownership
Who owns Audentes Therapeutics?
Audentes Therapeutics is owned by Astellas Pharma. It was acquired on December 2, 2019.
Audentes Therapeutics Business Overview
Where is Audentes Therapeutics headquartered?
Audentes Therapeutics is headquartered in San Francisco, California.
What is Audentes Therapeutics’ revenue?
Audentes Therapeutics disclosed revenue of 134M USD for 2018 and 93M USD for 2017.
How many employees does Audentes Therapeutics have?
Audentes Therapeutics has 207 employees.
What sector is Audentes Therapeutics in?
Audentes Therapeutics is a life science company.
When was Audentes Therapeutics founded?
Audentes Therapeutics was founded in 2012.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1